Cutler Group LP Seagen Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$191.51 - $216.16 $383,020 - $432,320	2,000 Added 153.85%	3,300 $40,000
Q2 2023 Jul 18, 2023	BUY	$187.64 - $206.25 $243,931 - $268,125	1,300 New	1,300 $4,000
Q3 2022 Oct 25, 2022	SELL	$135.27 - $180.11 $1.01 Million - $1.35 Million	-7,500 Reduced 77.32%	2,200 $4,000
Q2 2022 Aug 04, 2022	SELL	$108.81 - $179.33 $97,929 - $161,397	-900 Reduced 8.49%	9,700 $171,000
Q4 2021 Jan 18, 2022	BUY	$142.57 - $190.86 $1.51 Million - $2.02 Million	10,600 New	10,600 $33,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.